Clostridial neurotoxins have assumed increasing importance in clinical application. The toxin's light chain component (LC) inhibits synaptic transmission by digesting vesicle-docking proteins without directly altering neuronal health. To study the properties of LC gene expression in the nervous system, an adenoviral vector containing the LC of tetanus toxin (AdLC) was constructed. LC expressed in differentiated neuronal PC12 cells was shown to induce time-and concentration-dependent digestion of mouse brain synaptobrevin in vitro as compared to control transgene products. LC gene expression in the rat lumbar spinal cord disrupted hindlimb sensorimotor function in comparison to control vectors as measured by the Basso-Beattie-Bresnahan (BBB) scale (Po0.001) and rotarod assay (Po0.003).
Introduction
Clostridial neurotoxins (CNTs), and other applications of focused neural inhibition, have assumed increasing importance as therapies for a variety of neural disorders stemming from an imbalance of neural activity. Delivery of the gene for the light chain fragment (LC) of these toxins represents an alternative means for focused neural inhibition with inherent advantages over existing methods. Recent work in transgenic mice has demonstrated that neuronal LC expression can induce a reversible inhibition of synaptic function. 1 Potentially reversible synaptic inhibition delivered to anatomically discrete neural targets through LC gene transfer could be applied to a variety of disease targets as well as to the study of neural circuits.
The use of botulinum neurotoxin (BoNT) in the clinic has increased dramatically in the past decade. Initially developed as a means to treat strabismus, BoNT is currently applied to a variety of disorders stemming from imbalanced neuromuscular activation including dystonia, blepharospasm, and hemifacial spasm. 2 The off-label clinical applications include spasticity, 3, 4 focal hyperhidrosis, 5 classical achalasia, 6 hyperactive bladder, 7 and headache. 8 The observation that wrinkles are associated with the activation of facial muscles has led to the increasing application of BoNT in cosmetic procedures. 9 Despite its expanding clinical applications, BoNT's transient effect creates a need for repeated injections that results in immune recognition and consequent tolerance. 10 Further, BoNT cannot be used to treat the brain nuclei that are emerging as targets for therapeutic neural inhibition.
Focused neural inhibition has mainly been achieved through surgical lesions in the nervous system and electrical stimulation. Deep brain stimulation (DBS), which utilizes implanted electrodes to deliver focal electrical current to the brain, is currently approved for the treatment of Parkinson's disease (PD), dystonia, and tremor by the FDA. 11 Electrical stimulation is also widely applied to the control of chronic pain. Despite expanding applications of this form of focused neural inhibition, DBS therapy has limitations. The need for implanted hardware leaves this therapy vulnerable to malfunction, disconnection, and infection, in addition to requiring periodic surgical procedures for battery replacement. Our laboratory 12 and others 13 have explored the delivery of the glutamate decarboxylase (GAD) gene as an approach to gene-based neural inhibition. This approach is currently being applied in the human subthalamic nucleus as a possible treatment for Parkinsonian symptoms.
14 Focused LC gene expression within the nervous system may provide an alternative strategy for gene-based inhibition in the central nervous system (CNS).
BoNTs and tetanus neurotoxin (TeTx) are produced by Clostridium botulinum and Clostridium tetani, and are responsible for the paralytic syndromes of botulism and tetanus, respectively. The seven BoNTs and one TeTx make up the CNT family. 15, 16 Neuronal CNT intoxication consists of four steps: binding, internalization, membrane translocation, and proteolytic cleavage of specific cellular targets. All eight CNTs are produced as inactive polypeptide chains of B150 kDa and released after bacterial lysis. The inactive single chain molecules are cleaved by endogenous or exogenous proteases to form an active di-chain molecule. The di-chain formation is characterized by a single disulfide bond, which links the light chain (LC, B50 kDa) and the heavy chain (HC, B100 kDa). The B100 kDa HC contains two functional domains, individually responsible for neuronal membrane binding and membrane penetration. 15 The B50 kDa LC is responsible for the intracellular activity of CNTs acting as a zinc-dependent endopeptidase. 17 Depending on their subtype, LCs cleave one of three proteins involved in synaptic vesicle membrane fusion: VAMP (vesicle-associated membrane protein, also called synaptobrevin), SNAP-25, or syntaxin. These proteins are collectively termed SNARE (SNAP receptor) proteins. Tetanus toxin LC cleaves the single Gln-76-Phe-77 bond of VAMP-1. Cleavage of any one of these three proteins disrupts neurotransmitter release, blocking neurotransmission. 18, 19 Therefore, intracellular LC expression should be capable of synaptobrevin digestion and consequent synaptic inhibition. The inadvertent release of LC does not pose a threat since this proteolytic fragment is not capable of neuronal binding and uptake without the HC.
The present study tests the hypothesis that neural LC expression induces neural inhibition through SNARE disruption without inducing neuronal cell death. We cloned the tetanus toxin light chain component gene (LC) into an adenoviral vector (AdLC). Infection of differentiated PC12 neuronal cells led to the production of the LC fragment in these cells. This transgenic LC protein was capable of time-and concentration-dependent VAMP digestion in vitro. To test AdLC gene transfermediated synaptic inhibition in vivo, the virus was injected into the rat lumbar spinal cord. LC gene expression in the rat lumbar spinal cord was found to induce flaccid paralysis of the rat hindlimb. Behavioral assays demonstrated a statistical difference between AdLC-injected rats and the control rats injected with either adenovirus containing Escherichia coli b-galactosidase (AdLacZ) or adenovirus containing green fluorescent protein (AdGFP). Evoked electromyography (EMG) demonstrated increased stimulus threshold and decreased response current amplitude localizing the critical effect of spinal cord LC expression to the neuromuscular junction. To rule out the possibility of cytotoxic effects related to LC gene expression, motor neuron (MN) density and DNA fragmentation were evaluated at the peak of neuromuscular inhibition. DNA fragmentation was not detected in MNs, and no difference in neuronal density could be detected between the AdLC and AdGFP treatment groups. To reinforce the notion that MNs tolerate LC gene expression, AdLC-and AdGFP-injected rats were observed for 1 month following unilateral viral injection. These animals showed nearly complete recovery of function in parallel with the cessation of spinal cord gene expression. We conclude that LC gene expression in spinal MNs induces a neuromuscular blockade through the disruption of VAMP-dependent synaptic transmission. This novel form of neural inhibition may find applications in the treatment of neurological diseases as well as in the study of neural circuits.
Results

LC gene expression from AdLC vector
The gene encoding the clostridial tetanus toxin LC was cloned into an adenoviral vector under the control of the CMV promoter (pAdLC). The IRES (internal ribosome entry site)-driven GFP sequence was also cloned into this vector downstream of the CMV-LC sequence in order to track gene expression in vitro and in vivo (Figure 1a ). 
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A first-generation adenovirus was generated from this vector through Cre-mediated in vitro recombination between the vector plasmid pAdLC and the 3 0 adenoviral sequence. Virus was amplified by propagation in HEK 293 cells. To confirm the LC expression from this adenovirus vector, HEK 293 cells were infected with AdLC virus. Cell lysates from infected HEK 293 cells were Western blotted using primary antibodies against the LC and b-actin proteins. Lysates from cells exposed to PBS or AdLacZ were run as negative controls. Purified recombinant LC protein was run as a positive control. As shown in Figure 1b , the 52 kDa LC protein was expressed in HEK 293 cells infected with AdLC but not negative controls. b-Actin staining showed no apparent protein loading variations between the experimental and negative control conditions. The inclusion of IRESdirected GFP gene also allowed us to monitor gene expression by detecting the GFP protein under a fluorescent microscope (Figure 1c ).
LC expression induces time-and concentrationdependent VAMP-1 digestion
Clostridial tetanus neurotoxin LC is a highly selective metalloprotease, which cleaves the single Gln-76-Phe-77 bond of VAMP-1. 17 To test the endopeptidase activity of LC produced in neurons following adenoviral gene transfer, we developed a simplified in vitro assay system. Based on their neuronal phenotype, differentiated PC12 cells were chosen to demonstrate adenovirus vectormediated LC protein production. Crude cell lysates from AdLC-infected PC12 cells were used for enzymatic reactions without further manipulation. This step eliminated the expensive and time-consuming toxin purification steps required for most previously documented CNT assays. 20 Protein extracted from mouse cortex (MCP) containing VAMP-1 was used as a source of LC substrate. The digestion was carried out in a buffer system (see Materials and methods), which has been previously shown to support the enzymatic activity of LC. 17, 21 The density of the 18 kDa mouse brain VAMP-1 band, detected on anti-VAMP-1 Western blots, deteriorates as a function of the duration of incubation with AdLC PC12 lysates, but not AdLacZ PC12 lysates ( Figure  2a ). Reprobing the same blot with an anti-LC antibody revealed a consistent level of LC in AdLC lysates. Additionally, reprobing the blot with an antibody against b-actin demonstrated balanced protein loading. Taken together, we conclude that the deterioration of VAMP band density was dependent on the duration of exposure to the LC gene product, rather than a variation in MCP or LC used in the reaction mixture. As expected, no signals specific to LC antibody were detected in AdLacZ lysates or mouse cortex protein. In a similar fashion, VAMP-1 bands showed reduced density at higher concentrations of the AdLC PC12 lysate (Figure 2b ). Reprobing the blot with the LC antibody revealed the predicted increase in LC concentrations in AdLC lysates but not the AdLacZ or MCP control lysates. Reprobing of the blot with the b-actin antibody showed the expected increase of signal correlated with the increasing amount of AdLC cell lysate used in the reaction mixture. To prove that the amount of MCP used in this digestion was the same in all reactions, all samples were split equally. Half of the paired samples were subjected to lysate exposure, while the remaining samples were blotted without lysate exposure. Without lysate exposure there was no variation in either VAMP or b-actin (data not shown). Figure  2b demonstrates that the LC gene product produces a concentration-dependent digestion of VAMP-1. At the same concentration of PC12 lysate, AdLacZ samples produce no VAMP-1 digestion. The increase in b-actin and LC band density corresponds to the increasing lysate concentration and varies inversely with the VAMP-1 band density. The anti-VAMP-1 antibody in our Western blot assay is specific for full-length VAMP-1 protein. We were therefore unable to detect the two smaller digested protein fragments of VAMP-1.
Spinal cord LC transgene expression impedes rat sensorimotor function
To test whether LC gene expression induces sensorimotor dysfunction in vivo through the disruption of synaptic vesicle docking, rat lumbar spinal cords were injected bilaterally with AdLC, AdGFP, and AdLacZ. Following 
. In contrast to the group treated with 8 Â 10 7 PFU of AdLC, the group receiving one tenth the titer of viral suspension (8 Â 10 6 PFU; AdLC/10) showed no change in locomotion on any of the 5 days of testing. We therefore conclude that LC gene expression in spinal cord induced titer-dependent motor dysfunction in rats.
The rotarod assay of motor performance measures the maximum rotational velocity (V max ) at which a rat can maintain balance on a spinning dowel. This task requires intact sensorimotor function in all limbs, thus providing a more objective and investigator-independent assessment of hindlimb motor performance. As with BBB assessments, rotarod testing was performed on each of the 5 days following vector injection. At 2 days after injection, AdLC-injected animals were only capable of reaching 23.75% of their preinjection V max baseline ( Figure 3d ). Two-way ANOVA statistics demonstrated a significant decrease in rotarod V max following AdLC gene transfer to spinal cord as compared to the lower AdLC/10 concentration, the AdGFP, and AdLacZ (Po0.0001, df ¼ 3, F ¼ 11.23) control groups. These results confirmed LC expression-dependent deterioration in hindlimb sensorimotor function.
LC gene transfer induces decreased EMG response and increased stimulus threshold
To demonstrate that the observed sensorimotor dysfunction in vivo was mediated by impaired synaptic function at the neuromuscular junction, evoked EMG was measured in animals after spinal cord gene transfer. Compound muscle action potentials were measured in the gastrocnemius muscle after sciatic nerve stimulation immediately following recovery from spinal cord injection in the left lower extremity, and 5 days after injection in the right lower extremity. Current amplitude was Light chain gene-based synaptic inhibition Q Teng et al increased by 0.1 mA intervals in order to measure the threshold for evoked motor response in the gastrocnemius. The latency to response onset is approximately 1 ms, reflecting the proximity of the stimulated region of the nerve to the muscle body. Consequently, the onset of the evoked response was typically obscured by the stimulus artefact. The evoked response recorded at 0.5 mA of sciatic stimulation on days 1 and 5 in the AdGFP-injected control animals, although morphologically different, showed a similar stimulus/response amplitude relationship (Figure 4a ). In contrast, the same level of stimulation evoked a robust response in AdLCinjected animals on day 1 but not on day 5 (Figure 4a ). While no change in stimulus response threshold was detected in AdGFP-injected animals, the threshold for evoked gastrocnemius EMG tripled between the day of surgery and postsurgery day 5 in AdLC-injected animals.
Furthermore, the extinction pattern for the response in control and experimental animals across the two test days also showed a marked difference. On day 1, animals injected with either AdLC or AdGFP had a build-up of EMG activity that peaked approximately 4-5 ms after stimulus onset. Subsequently, the magnitude of the response diminished, or weakened, as the synapse was overdriven. Figure 4b demonstrates that this pattern was preserved in the control animals 5 days postsurgery. The extinction pattern was absent in the AdLC-injected experimental animals even at more than twice the initial current level. When the response appeared, it was at a stimulus amplitude that was three times that required on day 0 and showed a distinctly different pattern marked by a profound delay in the response build-up. Taken together, evoked gastrocnemius EMG response to sciatic stimulation demonstrates that spinal cord LC expression profoundly altered synaptic transmission at the neuromuscular junction. 7 PFU). A morphed atlas of spinal cord anatomy was overlain to provide a context for the GFP distribution. 22 Since injection sites were slightly staggered, gene expression in individual slices appears to be asymmetric. (Figure 6a and b) . In contrast, examination of spinal cord histology in the long-term cohort 1 month after injection showed only minimal persistent gene expression.
LC gene expression does not cause detectable cell death
Practical application of neuronal LC gene expression requires that it function through synaptic disruption, rather than neuronal death. However, the sensorimotor and evoked EMG results could be explained through either mechanism. Yamamoto et al 1 recently reported that tetracycline-regulated LC expression in cerebellar granule neurons induced a transient behavioral effect on motor function. The recovery of motor function in their study implies that LC gene expression in neurons is not cytotoxic. However, to rule out the possible cytotoxicity associated with viral LC transgene expression in our study, the effect of LC gene expression on MN density was measured in the rat spinal cord during the peak of adenovirus gene expression and neuromuscular inhibition. In addition, Terminal deoxynucleotidyl end labeling (TUNEL) staining was performed on spinal cord sections to identify DNA fragmentation that might indicate evolving neuronal death not apparent in cell density counts. Both MN density and TUNEL staining were evaluated in the region of greatest transgene expression. TUNEL staining cells had a uniformly small size without identified axons. No positive TUNEL staining was detected in cells with MN morphology. The number of TUNEL-positive cells in AdGFP-injected animals was statistically indistinguishable from the number detected in AdLC-injected animals (P40.05). TUNEL staining positive only reveals cells in the process of apoptotic death. As such, this measurement may not detect neurons that have already died. Therefore, the number of intact MNs was counted in the spinal cords of AdLC and AdGFP at the point of maximal sensorimotor deficit. Long-term assessment of AdLC delivery into the rat spinal cord
Our previous experiments suggest that adenoviral gene expression in the spinal cord peaks during the first week after injection and disappears over the subsequent 3 weeks. 23 Adenovirus was chosen as the vector for our initial experiments on LC gene expression based on the prediction that gene expression would be transient in most animals. Despite the variety of data suggesting MN survival during LC expression and sensorimotor dysfunction, functional recovery is the clearest evidence that LC-induced neuromuscular blockade results from synaptic inhibition rather than MN death. To demonstrate recovery, animals underwent unilateral spinal cord injection with either AdLC or AdGFP (n ¼ 8). Prior to surgery, all rats had a BBB score of 21. Postsurgery, following a 2-h recovery, all animals were ambulating using all four limbs with an approximate BBB score of 21. The BBB score in the AdLC-injected animals decreased to Light chain gene-based synaptic inhibition Q Teng et al 10 on postsurgery day 5, reflecting a unilateral motor deficit in the injected side hindlimb. AdGFP controls fully maintained their locomotor abilities (BBB ¼ 21). On days 10-11, AdLC rats started improving with their BBB score increasing to 14.3, which still reflected significant motor deficit. However, the average AdLC BBB score on postsurgery day 20 reached 18.3, expressing overall good motor function with minor balance deficit and some decrease in consistency of paw positioning. At 1 month postsurgery, the average BBB in the AdLC rats remained stable at 19, demonstrating significant recovery of function as compared to day 5 postsurgery (Po0.05). AdGFP rats maintained BBB above 20, with one AdGFP rat decreasing BBB to 20 approximately 3 weeks postsurgery. This change, which reflects some loss of balance and tail positioning, may be due to the delayed gliosis and myelomalacia that has previously been noted in spinal cords injected with adenovirus. 23 Besides BBB measurement, a more sensitive motor function assessment tool, grip strength measurement, was also employed to assess the sensorimotor function in this cohort of long-term study. In the week prior to surgery, the average unilateral hindlimb grip strength was 254 g in AdLC rats and 231 g in AdGFP controls. Assessment of grip strength, illustrated in Figure 7 , demonstrated an AdLC-induced deficit in unilateral grip strength to À80% of baseline values on day 5, significantly different from AdGFP control group (Po0.05) which had no detectable deficit (0.15% baseline). At 10 days postsurgery, the grip strength deficit in the AdLC group was reduced to À31% of baseline, still significantly (Po0.05) different from controls (À0.66%) and decreased further to À19% on day 20 and stabilized to À20% around 30 days postsurgery, statistically not significant (P ¼ 0.16). The control AdGFP group demonstrated a slight decrease in grip strength at 30 days postsurgery (À8%) due to a minimal decrease in function in one rat, which did not reach statistical significance. Thus, both BBB assessments and unilateral hindlimb grip strength measurements demonstrate almost complete recovery of hindlimb function that parallels the previously documented time course of adenoviral gene expression. This observation eliminates the possibility that LC gene-based neuromuscular blockade could result from MN death.
Discussion
The present study demonstrates that the enzymatically active clostridial LC can be produced in neurons through viral gene transfer and disrupt synaptic function in vivo. This transgenic toxin fragment is capable of time-and concentration-dependent synaptobrevin digestion in vitro. The present data also replicates our previous finding 23 that direct spinal cord injection of adenoviral vectors induces transient gene expression in multiple cell types including neurons without altering sensorimotor function. In contrast to the unaltered behavior in control groups, LC expression creates a titer-sensitive depression in neural function in the rat spinal cord. Sciatic nerve evoked gastrocnemius EMG demonstrates that spinal cord LC expression dramatically inhibits neuromuscular synaptic transmission. Histological comparison of AdLC and AdGFP spinal cords during the peak of gene expression shows no neuronal DNA fragmentation, no difference in DNA fragmentation in non-neural cells, and no change in MN density. Using a unilateral injection model, neuromuscular inhibition occurs asymmetrically demonstrating that the functional effects of AdLC injection are anatomically discrete. Finally, long-term assessment of hindlimb behavior after AdLC injection revealed nearly complete recovery of the rat sensorimotor function. Taken together, these results strongly suggest that LC gene expression alters spinal cord function through the disruption of VAMP-dependent synaptic transmission at the neuromuscular junction. These findings indicate that we had achieved a focal in vivo synaptic inhibition through neuronal synaptobrevin digestion via adenovirus-mediated gene transfer.
The neuromuscular dysfunction documented in our EMG and behavioral experiments could be explained by either MN death or synaptic inhibition. There is a variety of evidence that a threshold of MN loss is necessary for weakness to be observed. In cases where multiple nerve roots innervate a single muscle group, loss of a single root may not cause accompanying weakness. Similarly, in polio, asymptomatic limbs can show evidence for MN loss on EMG studies. 24 In patients with MN disease, the motor unit number estimate (MUNE), which approximates the number of surviving neurons, drops prior to the onset of symptomatic weakness. 25 Thus, a dramatic amount of MN death would be required to explain the profound paralysis observed 5 days after bilateral AdLC injection in our study. The observation that neither neuronal TUNEL staining nor a change in MN density can be detected in the region of gene expression during the peak of weakness renders MN death an extremely unlikely cause of the observed behavior. Taken together with the functional recovery observed in long-term experiments, AdLC-induced weakness cannot be attributed to MN death.
In addition to the data provided in the present experiment, evidence exists that neurons tolerate both LC protein and gene expression. Recovery of synaptic function following clinical tetanus 26 or botulism 27 demonstrates that neurons survive LC exposure. Figure 7 AdLC-induced hindlimb paralysis spontaneously resolves. Rats injected unilaterally with 3.9 Â 10 7 PFU of AdLC showed a peak motor deficit at day 5 with significant recovery by 1 month after injection (Po0.05). Hindlimb right-sided grip strength deficit derived by comparing treated and untreated sides was plotted to the preoperative baseline. This assay showed full recovery in AdLC rats at 1 month (P ¼ 0.16) and no deficit in AdGFP controls injected with 4.0 Â 10 7 PFU of AdGFP.
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Furthermore, the recovery of neuromuscular function after long-term holotoxin therapy renders the possibility that LC causes permanent dysfunction or cell death unlikely. 28 Neither BoNT A nor BoNT C affected motor unit survival in human clinical trials. 29 More recently, Yamamoto et al 1 have noted that expression of LC in cerebellar granule cells induces reversible alterations in neural function suggesting that no permanent damage to neural circuits occurs.
The present data provide evidence that LC can be redirected through viral gene transfer, thereby producing symptoms different from CNT holotoxin intoxication. TeTx holotoxin induces spastic paralysis due to LC activity in inhibitory spinal interneurons 30, 31 or epilepsy due to its activity in hippocampus. 32 Unlike the effect of TeTx holotoxin, adenoviral LC gene delivery induced a flaccid paralysis secondary to the neuromuscular blockade. This is the first study to implicate LC in the production of flaccid paralysis, confirming that the spasticity induced by the TeTx holotoxin results from its pattern of delivery but not the intracellular action of LC. This observation is consistent with the theory that tetanus toxin's affinity for inhibitory interneurons is derived from the specific tropism of the HC, rather than LC specificity.
LC gene expression has the potential for application in a variety of therapeutic and experimental contexts. BoNT has been used to treat a variety of disorders stemming from maladaptive MN activity including spasticity, dystonia, strabismus, blepharospasm, spastic bladder, achalasia, hyperhidrosis and chronic pain problems. 33 The present study suggests that viral delivery of the LC gene induces synaptic inhibition through a mechanism similar to that of BoNT. As such, the availability of MN vector targeting, [34] [35] [36] inducible promoters, 37 and safe advanced generation vectors 38 could provide broad therapeutic applications for neuronal LC gene expression.
The observation that viral LC gene delivery can redirect the protease's activity suggests that LC expression might have effects on a variety of neuronal subtypes and other secretory cell types. Electrolytic lesions, 39 electrical stimulation, 40 and chemical inhibition 41, 42 of deep brain nuclei have all proven therapeutic in movement disorders. Since the effects of LC expression are reversible and tolerated by neurons, LC gene transfer to deep brain nuclei may be applied as an alternative to these approaches. Similar application of the GAD transgene forms the basis for the only ongoing clinical trial in human Parkinson's disease.
14 Synaptobrevin is also reported to play a role in the release of hormones. 43 We therefore speculate that LC gene delivery could block exocytosis in endocrine tissues as it does in the CNS. Vectors harboring the LC gene could then be applied as a means to inhibit pathological hormone secretion in medically refractory conditions. Finally, in addition to providing novel therapeutic approaches, the ability to reversibly suppress focused regions of the CNS presents an elegant means to experimentally dissect neural function. 44 Importantly, the LC protein itself is inert unless it is delivered to the intracellular space of cells that depend on synaptobrevin for their function. BoNTs and the TeTx have a carbohydrate or lectin recognition domain that lies in the carboxyl-terminal half of the HC, and facilitates specific polysialoganglioside receptor binding. 45 Both BoNTs and TeTx gain entry into cells through the neuromuscular junction, following different trafficking routes to their target cells. In the absence of the HC, LC cannot cross the cellular membrane or blood-brain barrier preventing LC release from posing a threat to animal health. In compliance with institutional biosafety oversight at the Lerner Research Institute in Cleveland Clinic Foundation, intramuscular, intravenous, and endotracheal AdLC were tested with no deleterious side effects.
In conclusion, viral LC gene delivery can induce focused neural inhibition without killing cells. LC gene delivery may possess several characteristics that can lend the technique to clinical application in a variety of disease processes resulting from imbalanced neural activity and maladaptive secretion. In addition, LC gene delivery may also prove to be a valuable tool for the study of neural circuitry.
Materials and methods
Recombinant adenovirus production and purification
A 1496 bp synthetic gene encoding the LC of tetanus toxin protein was cloned into the adenovirus vector pACCMVpLpA(-)loxP.SSP. For easier identification of gene expression in vitro and in vivo, the IRES-GFP sequence was cloned into this vector downstream of the LC gene (Figure 1a) . The resulting vector was named pAdLC. Using this plasmid, a recombinant adenovirus vector (AdLC) containing LC and IRES-GFP sequences was produced according to a published protocol. 46 AdLC virus was purified by a standard cesium chloride purification protocol. 47 Two similarly attenuated (E1A, E1B, and E3 deleted) Ad5 vectors, produced and purified following the same protocol, were used as control vectors in this study. The first (AdLacZ) contains the E. coli reporter gene LacZ under the control of the CMV promoter. The second (AdGFP) contains the GFP reporter gene under the control of Rous sarcoma virus (RSV) promoter. An anti-LC Western blot was performed on HEK 293 cell lysate after adenovirus infection to verify the expression of LC in AdLC but not AdLacZinfected cells. The BCA protein assay (Pierce, Rockford, Illinois) was used on all samples prior to loading in order to confirm equal protein concentrations across lanes. The Western blot was also probed with an anti-b-actin primary antibody to confirm equal protein loading.
LC endopeptidase activity assay in vitro
Differentiated PC12 cells, induced with nerve growth factor (NGF) (Sigma-Aldrich, St Louis, MO, USA) at a concentration of 50 ng/ml, were infected with AdLC, AdLacZ, or AdGFP virus at a multiplicity of infection (moi) of 5 for 48 h. The resulting cell lysate was used as the source of LC protein and control protein for the subsequent enzymatic digestion of mice cortex tissue containing synaptobrevin. Mouse cortex protein (MCP) (10 mg) was incubated with protein obtained from adenovirus-infected PC12 cells in Light Chain Reaction Buffer (5 mM HEPES, 0.3 M glycine, 0.3 M NaCl, 0.02% NaN 3 , pH 7.4) at 371C. To test the time dependence of synaptobrevin digestion by the transgenic LC, incubation was performed for 6, 12, 18, 24, and 48 h with 10 mg of Light chain gene-based synaptic inhibition Q Teng et al cell lysate from cells infected with AdLC and for 24 and 48 h with 10 mg of AdLacZ cell lysate. A concentrationresponse curve of cortical synaptobrevin digestion was also carried out with 0.5, 2.5, 5.0, 7.5, and 10 mg of AdLC cell lysate. Following incubation, the reaction mixtures were loaded on a PAGE gel and Western blots were performed using an antibody against synaptobrevin (VAMP-1) protein (Santa Cruz Biotechnology, Santa Cruz, CA, USA). As in first experiment, the BCA protein assay was used on all samples prior to loading in order to confirm equal protein concentrations across lanes. These blots were stripped and reprobed for LC protein using an anti-LC antibody. This band served to confirm equal LC loading in the time-course experiment and the inverse relationship of LC to VAMP protein band density in the concentration-response experiment. Finally, all blots were restripped and probed with an antibody against b-actin as a protein loading control. To confirm results, both experiments were carried out four times by different researchers.
Gene delivery of AdLC virus into rat spinal cord
All experimental protocols were reviewed and approved by the Cleveland Clinic Foundation Institutional Biosafety Committee and Animal Care and Use Committee. Experiments strictly adhered to the Guide for the Care and Use of Laboratory Animals (National Academy of Sciences Press, Washington, DC, 1996). Adult female SpragueDawley rats (Harlan, Indianapolis, IN, USA), weighing 150-250 g, were served as experimental subjects. Using standard techniques, 48 rats were randomly assigned to four groups and trained to run on the Economex rotarod apparatus (Columbus Instruments, Columbus, OH, USA) for 1 week prior to surgery. The day prior to surgery, locomotion was assessed on the 21-point BBB scale. 49 Rats were anesthetized with isoflurane (3% in O 2 ) and placed in a Kopf stereotaxic frame (David Kopf Instruments, Tujunga, CA, USA) to restrict movement. A dissecting microscope (Stereozoom 6; Leica, Buffalo, NY, USA) was used for all surgical procedures. A 2 cm midline incision was made over the lumbar lordosis. The L2 spinous process was identified and removed, taking care not to tear the underlying dural membrane or traumatize the spinal cord. The dura mater was then incised with a microscalpel. Spinal cord injections were performed with an oocyte microinjector (Nanoject; Drummond, Broomall, PA, USA) mounted with glass micropipettes. A glass micropipette puller (PP-83; Narishige, Tokyo, Japan) was used to create tapered tips on micropipettes, which were then beveled to 100 mm under microscopic visualization. Micropipettes were advanced through the pia mater into the spinal cord parenchyma to a depth of 2 mm using a micromanipulator (N-152; Narishige, Tokyo, Japan) 1 mm lateral to midline. Injections were performed gradually over a 15-min period to minimize reflux of the viral solution and spinal cord trauma. The virus was also injected on the contralateral side in the same way. The first group (n ¼ 4) received 10 ml injections of AdLC (titer 7.8 Â 10 9 PFU/ml). Control group rats received 10 ml of either AdGFP (n ¼ 4) or AdLacZ (n ¼ 4) (titer 8.0 Â 10 9 PFU/ml). The third control group rats (n ¼ 4) received 10 ml of diluted AdLC (titer 7.8 Â 10 8 PFU/ml). The primary effect was replicated with a separate independent blinded experiment comparing AdLC to AdGFP (n ¼ 8). In an additional series of experiments designed to track the long-term behavioral effects of LC expression, two groups of rats received unilateral lumbar spinal cord injections of 5 ml AdLC (titer 7.8 Â 10 9 PFU/ ml, n ¼ 4) and AdGFP (titer 8.0 Â 10 9 PFU/ml, n ¼ 4) following the protocol described above.
Animal behavioral assay
In the initial short-term LC expression experiment, rats were allowed to recover for 24 h following surgery. Since adenoviral gene expression is delayed in the spinal cord, 23 animals showing significant immediate postoperative hindlimb dysfunction were assumed to have a spinal cord injury related to surgery and were therefore excluded from further analysis. Based on these criteria, two rats were eliminated from the study. An investigator blinded to the treatment conditions assessed animal motor function over 5 sequential days using the locomotor BBB scale. 49 The criteria for rating on the 21-point scale (21 ¼ normal motor function, 0 ¼ no observable hindlimb movement) are adopted from Basso et al 49 The second motor function assay tested the maximal speed (V max ) at which rats were able to remain on the rotarod apparatus. The Economex rotarod apparatus has previously been utilized to efficiently assay the behavioral impact of progressive MN disease. 48 Performance on the rotarod tests both forelimb and hindlimb function as well as balance. Following establishment of the baseline motor performance at 5 r.p.m. (rotations per minute), the rotarod was accelerated by 0.1 r.p.m./s increments and the time required for the animal to fall off the rotarod was observed. The maximal speed (V max ) at which the rat was able to remain on the rotarod was calculated with the following formula:
where t ¼ the time required for the animal to fall from the rotarod, a ¼ the acceleration of the rotarod apparatus and, s ¼ the start up speed.
Motor performance was assessed daily for 5 consecutive days after surgery.
In a second cohort of animals injected unilaterally, behavior was tracked for 1 month after surgery. The animals were tested weekly on the BBB scale as previously described, starting in the first preoperative week, for a total of 5 weeks. In addition, muscle strength of each hindlimb was measured using an automated Grip Strength Meter (Columbus Instruments, Columbus, OH, USA). The Grip Strength Meter provides a validated measurement of motor function. The instrument uses an electronic digital force gauge that measures the peak force exerted upon it by the action of the animal. For the hindlimb grip strength measurement, the rat was first held by the observer with its back facing the sensor. The rat forepaws were then supported and the animal was allowed to place each individual hindpaw on the angled wire mesh of the pull bar. These handling maneuvers allowed the animal to grasp the pull bar with the hind paws. The animal was slowly pushed towards the pull bar at a rate of 2-3 cm/s until it released the pull bar. Peak compression was recorded from the force gauge's digital readout. Each rat was tested in five sequential trials and the highest value was considered. Motor function assessment in each hindlimb was assessed weekly, starting from presurgery, for a total of 5 weeks.
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The presurgery values of both limbs were averaged in each rat and considered the baseline value for that animal. Grip strength motor function in the injected and noninjected side was expressed as percent baseline. The motor deficit was calculated as the difference between hindlimb values in the injected and noninjected sides.
Spinal cord transgene expression
At 5 days after injection, rats were euthanized with intraperitoneal pentobarbital, and underwent transcardiac perfusion with 2% paraformaldehyde (SigmaAldrich Co, St Louis, MO, USA). Spinal cords were dissected, postfixed overnight and transferred to a 20% sucrose solution for 24 h. Spinal cords were cut serially in 20 mm sections using a Jung Frigocut 2800 cryostat (Leica Microsystems, Nussloch, Germany) and mounted on precleaned superfrost plus microslides. The tissue was stained for LacZ gene expression using a b-gal kit (Invitrogen Life Technologies, Carlsbad, CA, USA) and counterstained with cytoplasmic eosin. GFP expression was detected under a fluorescent microscope. MNs expressing GFP in sections of the rat spinal cord after gene transfer of AdLC and AdGFP were histologically identified on sections of lumbar spinal cord using established morphological criteria. Tissue sections were compared for qualitative differences indicative of structural damage.
Sciatic nerve stimulation/gastrocnemius muscle recording
A third category of in vivo experiments were designed to test the response of gastrocnemius muscle to sciatic nerve stimulation following AdLC and AdGFP control delivery to the rat lumbar spinal cord. Rats were anesthetized and injected into lumbar spinal cord bilaterally with 10 ml of AdLC and AdGFP viral suspension as described above. Following viral delivery, rats were allowed to recover and ambulate. They were then anesthetized with isoflurane and placed under the dissecting microscope. The skin was incised 2-3 cm lateral to the lumbar spine. The muscle planes were carefully separated avoiding injury of blood vessels or nerves and the sciatic nerve was exposed as well as a large area of the gastrocnemius muscle. A subminiature electrode (Model AH50-1650, Harvard Apparatus, Holliston, MA, USA) was applied on the exposed sciatic nerve and secured in place. Gastrocnemius EMG responses were obtained via a pair of surface electrodes (Sensormedics, Anaheim, CA, USA) with an exposed contact diameter of 2 mm. The electrodes were placed 1 cm apart and secured to the surface of the exposed muscle body. Evoked EMG was recorded from each animal approximately 2 h postsurgery and again on postsurgery day 4 when the AdLC rat demonstrated significant bilateral motor deficit (BBB ¼ 5). The AdGFP rat did not present any detectable motor dysfunction. For the present investigation, EMG was recorded from the right hindlimb on day 0 and from the left hind limb on day 4 in each animal. The EMG signals were amplified (Leadpoint, Medtronic Functional Diagnostics, Copenhagen, Denmark) and digitized (PCI-6071E, National Instruments, Austin, TX, USA) at a rate of 10 000 samples/s to a PC computer. Analyses were performed off-line using software developed under the Labview platform (National Instruments, Austin, TX, USA).
EMG was evoked by electrical stimulation through the subminiature electrode encompassing the exposed sciatic nerve. Square-wave, constant current pulses were delivered with a pulse width of 90 ms using a Grass Model S88 stimulator connected to a Model SIU7 stimulus isolation unit (Grass-Telefactor, West Warwick, RI, USA). Trains of stimuli were delivered with intratrain pulse rates of either 5 pulses/s (pps) or 80 pps. The 80 pps condition was included to observe the pattern of response extinction. For the purpose of analysis, the RMS value for the evoked response to each stimulus pulse was calculated. These values were then 5 bin-averaged (each point representing approximately 62 ms) and plotted over the 60-s period of stimulation.
Cytotoxicity assay of LC gene expression MN counts and spinal cord TUNEL staining were analyzed after in vivo adenoviral gene delivery into the rat spinal cord during the peak behavioral effect of LC expression. Lumbar spinal cords of rats killed on day 5 postinjection were dissected, postfixed in 2% paraformaldehyde, serially sectioned on the cryostat. Slides were coverslipped with antifading gel for microscopic analysis. Prior to coverslipping, 20 mm spinal cord sections were TUNEL stained using an Apoptag Apoptosis detection kit (Serologicals, Norcross, GA, USA). TUNEL-positive cells were visualized microscopically and counted in four random fields from four separate slides for both AdLC and AdGFP conditions. These conditions were selected for comparison based on the indication that GFP may have inherent neurotoxicity. 50 The percentage of TUNEL-positive cells for each condition was calculated and statistically analyzed. In addition, positive fluorescent cells in the anterior horns of lumbar spinal cord were identified on the fluorescent microscope and serial pictures of identical size fields were taken from AdLC-and AdGFP-injected spinal cords. All torn tissue and fuzzy images were discarded to avoid artefacts. The unique morphology of spinal MNs allows for easy identification based on cell size and shape. MNs were counted in each field and averaged for each animal to yield a measurement of mean MNs per field for each animal. The mean MNs per field for the AdGFP and AdLC groups were statistically compared.
Statistical analysis
TUNEL-positive MNs and MN cell numbers in the rat spinal cord after gene transfer, and rat behavioral data (BBB scores, V max , and grip strength) were analyzed with Origin 7.0. Software. The mean density of MNs and TUNEL-positive cells per section from animals treated with AdLC and AdGFP were compared using a one-way ANOVA with multiple comparison procedures (Tukey Test).
Analysis of behavioral data utilized an intensive, within-subjects design. A BBB score was assigned to each subject daily and the mean (7s.e.m.) values for each treatment group was determined. Each animal was tested on the rotarod and the V max was calculated and expressed as a percentage of the presurgery baseline value. A value identical to the presurgery baseline was therefore equal to 100%. Repeated measures ANOVA was performed. One-way ANOVA and Tukey-Kramer Light chain gene-based synaptic inhibition Q Teng et al post hoc multiple comparison statistics compared the motor function parameter (either BBB scores or V max ) following AdLC, AdGFP, AdLacZ, and AdLC/10 injections at each time point. Time points included presurgery (day-1) and 5 days postsurgery (days [1] [2] [3] [4] [5] . Probability values of Po0.05 were regarded as statistically significant. Behavioral data from the long-term cohort was analyzed using Student t-test to compare AdLC and AdGFP groups at each time point. ANOVA was used to assess changes in motor function in the two groups across five time points.
